Animal studies have demonstrated that activation ofthe baroreflex by increases in arterial pressure inhibits cardiovascular and ventilatory responses to activation of peripheral chemoreceptors (PC) with hypoxia. In this study, we examined the influences of baroreflex activation on the sympathetic response to stimulation of PC and central chemoreceptors in humans. PC were stimulated by hypoxia (10% 02/90% N2) (n = 6) and central chemoreceptors by hypercapnia (7% C02/93% 02) (n = 6). Responses to a cold pressor stimulus were also obtained as an internal reflex control to determine the selectivity of the interactive influence of baroreflex activation. Baroreflex activation was achieved by raising mean blood pressure by > 10 mmHg with intravenous infusion of phenylephrine (PE). Sympathetic nerve activity (SNA) to muscle was recorded from a peroneal nerve (microneurography). During hypoxia alone, SNA increased from 255±92 to 354±107 U/min (P < 0.05). During PE alone, mean blood pressure increased and SNA decreased to 87±45 U/min (P < 0.05). With hypoxia during baroreflex activation with PE, SNA did not increase (50±23 U/min). Dur-ing hypercapnia alone, SNA increased from 116±39 to 234±72 U/min (P < 0.01). Hypercapnia during baroreflex activation with PE increased SNA from 32±25 U/min during PE alone to 61±26 U/min during hypercapnia and PE (P < 0.05). Like hypercapnia (but unlike hypoxia) the cold pressor test also increased SNA during PE. We conclude that baroreflex activation selectively abolishes the SNA response to hypoxia but not to hypercapnia or the cold pressor test. The inhibitory interaction of the baroreflex and the peripheral chemoreflex may be explained by convergence of baroreceptor and peripheral chemoreceptor afferents on neurons in the medulla. (J. Clin. In-
Introduction
Baroreceptor and chemoreceptor reflexes exert considerable influence on autonomic control of the circulation, especially in situations involving stressors such as marked changes in blood pressure and in blood levels ofoxygen and carbon dioxide. The individual contributions of baroreflexes and their responses to blood pressure alterations and of chemoreflexes and their responses to hypoxia and hypercapnia have been extensively studied in both animals (1, 2) and humans (3, 4) . Thus far, however, interactions ofthese reflexes have only been studied in animals. Heistad et al. have shown in dogs that baroreflex activation inhibits and deactivation augments the ventilatory response to stimulation of the peripheral chemoreceptors (5) . In addition, Mancia et al. have demonstrated that vasoconstrictor responses to peripheral chemoreceptor stimulation are inhibited by elevation of blood pressure and activation of baroreceptor reflexes (6) .
It has been difficult to study the interaction ofbaroreceptor and chemoreceptor reflexes in humans using measurements of vascular resistance and arterial pressure because the stimuli to these reflexes (vasoactive drugs and hypoxia) produce direct and confounding effects on the circulation. However, with the use of microneurographic recordings of sympathetic nerve activity (SNA),' it is feasible to study the interaction of these reflexes in normal humans. We have shown that both hypoxia (peripheral chemoreceptor stimulation [7, 8] ) and hypercapnia (primarily central chemoreceptor stimulation [9, 10] ) trigger increases in SNA in humans (4) . Furthermore, baroreflex activation inhibits SNA. We, therefore, examined the effect ofbaroreflex activation (elevation of systemic pressure using intravenous phenylephrine infusions) on sympathetic nerve responses to stimulation of peripheral chemoreceptors (by hypoxia), to stimulation ofcentral chemoreceptors (by hypercapnia), and to a cold pressor stimulus (used as an internal reflex control).
Methods
10 normal human volunteers (7 male, 3 female) aged 24±3 yr were studied. All were nonsmokers and receiving no medication. Measurements were taken of heart rate (EKG), breathing patterns (pneumotach), blood pressure (Physio-Control Lifestat 200 semiautomated sphygmomanometer; Redmond, WA), 02 saturation (Nellcor N-l 100 C pulse oximeter, Hayward, CA), end tidal CO2 (4721OA capnometer; Hewlett-Packard Co., Andover, MA), central venous pressure, and sympathetic nerve activity to muscle using microneurography (11). SNA was measured directly by inserting a tungsten microelectrode into a nerve fascicle to muscle in the peroneal nerve. Sympathetic bursts were identified by inspection ofthe mean voltage neurogram and sympathetic activity was calculated as bursts/min X mean burst amplitude and expressed in arbitrary units (12) . We also measured minute ventilation using a ventilation monitor (LS-75; Bourns, Riverside, CA).
Subjects were exposed to gas mixtures intended to induce either hypoxia (10% 02, 90% N2) or hypercapnia (7% CO2, 93% 02)-Subjects underwent measurement of baseline variables for 3 min while breathing room air. Then using a three-way valve, the subjects were exposed to either the hypoxic (six subjects) or hypercapnic (six subjects) stressors for 5 min. Average values for the 5-min period ofgas exposure were used in the comparisons. In one subject, responses to hypercapnia with and without phenylephrine (PE) were obtained over 3 min because of During hypoxia, hypocapnia secondary to the hyperventilation was avoided by titrating CO2 to maintain isocapnia.
We examined the effects of hypoxia and hypercapnia on SNA and compared these effects to those recorded when the baroreflexes were activated during the PE infusion. In four subjects, we further examined the effects of the cold pressor test (CPT) on SNA both in the baseline state as well as during the PE infusion. The CPT was performed by having subjects insert their hands to a predetermined depth into a container of ice for 2 min.
The effects of hypoxia, hypercapnia, and the CPT during the baseline state were compared with their effects during baroreflex activation (by the PE infusion) using the Wilcoxon's signed rank test. To assess minute by minute changes in the measured variables, the data were further analyzed using a repeated measures one-way analysis of variance (Table III) . Significance was assumed at the 5% level. Values are expressed as mean±standard error.
The study was approved by the University ofIowa Human Subjects Review Committee, and each subject gave informed written consent.
Results
(I) Effects ofhypoxia (Table I) (a) On baseline variables. During hypoxia, 02 saturation fell from 99±0.4% to 83±1.4% (P < 0.05), with an increase in minute ventilation (Vs) from 6.7±0.7 to 1 1.8±1.0 liters/min (P < 0.05) (Table III) , and an increase in SNA from 255±92 to 354±107 U/min (P < 0.05). MBP and central venous pressure (CVP) did not change.
(b) During phenylephrine. During PE alone, MBP increased by -10 mmHg (P < 0.05) and heart rate slowed by -11 beats/min (P < 0.05). CVP increased from 0.7±0.5 to (b) Duringphenylephrine. CPT during PE resulted in a further increase in MBP from 91±3.2 (PE alone) to 107±6.4 mmHg (P < 0.05). CVP was 5.2±0.5 during CPT alone, 5.7±0.5 during PE alone, and 5.7±0.8 with CPT during PE. Despite the increase in MBP with CPT during PE, SNA increased from 5.5±1.9 U/min during PE alone to 285±128 U/ min during CPT and PE (Fig. 5) .
Discussion
The major new finding in this study was inhibition ofthe sympathetic nerve response to hypoxia (peripheral chemoreceptor stimulation) by baroreceptor activation in humans.
A strength ofthis study was the direct measurement ofsympathetic nerve activity using microneurography. This enabled an analysis of these reflex interactions by providing a measure of the efferent sympathetic neural response A possible criticism is that the use of phenylephrine (an alpha agonist and therefore a vasoconstrictor) to activate the baroreflex may be associated with direct effects of phenylephrine (independent of the effects of the increased arterial pressure) on the chemoreceptors. If this were so, and vasoconstriction occurred in the chemoreceptors, we would expect an augmentation rather than an inhibition ofthe response to hypoxia, since vasoconstriction would increase the hypoxic stimulus. Furthermore, intravenous infusions of norepinephrine increase, rather than decrease the respiratory response to hypoxia in man (13) . In any event, any effects of phenylephrine on the baroreflex itself is unlikely to have influenced our findings, since any such effect would be present during both the hypoxic and hypercapnic stresses. With regard to possible effects of phenylephrine on the baroreflexes, the doses of phenylephrine used in this study do not sensitize the arterial baroreceptors to graded levels of neck pressure (14) .
We have confirmed earlier human studies demonstrating sympathetic neural activation by both hypoxia and hypercap- nia. More importantly, in this study we have shown in humans that baroreceptor activation inhibits the sympathetic responses to hypoxia. This baroreceptor-chemoreceptor interaction was previously described in animals (5, 6, 15, 16) . In humans, this interaction appears to be specific for hypoxia, which activates primarily peripheral chemoreceptors. In contrast, during baroreflex activation, sympatho-excitation still occurs during hypercapnia, which stimulates primarily central chemoreceptors. Sympatho-excitation is also present in response to a potent nonspecific stimulus such as the cold pressor test. This specificity ofthe interaction between the baroreceptors and the peripheral (but not central) chemoreceptors is remarkably similar to an interaction that we reported earlier where ventilation (and thereby activation of thoracic afferents) inhibited the sympathetic response to hypoxia far more profoundly than it inhibited the sympathetic response to hypercapnia (4 Fig. 1 ).
An unexpected finding in this study was that SNA tended to decrease (not increase) when hypoxia was imposed during baroreceptor activation with phenylephrine. Activation ofthe baroreflex may explain the failure of SNA to rise when peripheral chemoreceptors are stimulated by hypoxia, but why would SNA tend to decrease? There are two possible explanations. First, when hypoxia was imposed during PE, there was a slight increase in blood pressure which would produce further baroreflex inhibition of SNA. Second, when hypoxia was imposed during PE, there was an increase in ventilation which could inhibit SNA by activating thoracic stretch receptors.
We did not see an inhibitory influence ofbaroreceptor activation on the ventilatory response to hypoxia, as has been reported in animals (5). This may be explained by the fact that the magnitude ofthe pressure change in animal studies (> 100 mmHg) far exceeded the pressure increase in this study (-10 mmHg). The significance of this absence of any ventilatory inhibition despite sympathetic inhibition is that the baroreflex chemoreflex interaction may more profoundly influence the sympathetic limb ofthe chemoreflex as compared to the ventilatory limb.
The results of this study shed light on our earlier report of sympathetic hyperresponsiveness to hypoxia in borderline hypertensives (18) . We speculate that the baroreflex impairment known to occur in hypertension, may result in a loss of the inhibitory tonic or restraining influence of baroreceptors on the excitatory effect of chemoreceptors during hypoxia.
In conclusion, these data demonstrate a specific interaction between baroreceptors and peripheral chemoreceptors in regulation ofsympathetic nerve activity in normal humans. Activation ofbaroreceptors by increases in arterial pressure with phenylephrine markedly inhibit the sympatho-excitatory response to stimulation of peripheral chemoreceptors with hypoxia. This inhibitory influence of baroreceptor activation was not observed during stimulation of central chemoreceptors with hypercapnia.
